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Background: Many cancer patients receive a central venous catheter or port system prior to therapy to assure
correct drug administration. Even appropriate hygienic intervention maintenance carries the risk of contaminating
the middle port (C-port) of a three-way cock (TWC), a risk that increases with the number of medical interventions.
Because of the complexity of the cleaning procedure with disconnection and reconnection of the standard luer lock
cap (referred as “intervention”), we compared luer lock caps with a “closed access system” consisting of a luer access
split septum system with regard to process optimization (work simplification, process time), efficiency (costs) and
hygiene (patient safety).
Methods: For determination of process optimization the workflow of an intervention according to the usual
practice and risks was depicted in a process diagram. For determining the actual process costs, we analyzed use of
material and time parameters per intervention and used the process parameters for programming the process into
a simulation run (n = 1000) to determine the process costs as well as their differences (ACTUAL vs. NOMINAL)
within the framework of a discrete event simulation.
Additionally cultures were carried out at the TWC C-ports to evaluate possible contamination.
Results: With the closed access system, the mean working time of 5.5 minutes could be reduced to 2.97 minutes.
The results for average process costs (labour and material costs per use) were 3.92 € for luer lock caps and 2.55 €
for the closed access system. The hypothesis test (2-sample t-test, CI 0.95, p-value<0.05) confirmed the significance
of the result.
In 50 reviewed samples (TWC’s), the contamination rate for the luer lock cap was 8% (4 out of 50 samples were
positive), the contamination rate of the 50 samples with the closed access system was 0%.
Possible hygienic risks (related to material, surroundings, staff handling) could be reduced by 65.38%.
Conclusions: In the present research, the closed access system with a divided split septum was superior to
conventional luer lock caps. The advantage of the closed access system lies in the simplified handling for staff,
which results in a reduced risk of patient infection due to improved clinical hygiene.
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Cytostatics are standard treatment for cancer patients, for
example, for patients with esophagus carcinoma [1]. How-
ever, cytostatic drug protocols often have complex intraven-
ous infusion schedules with interventions up to 20 times
per 24 hours [2]. For this reason, many patients receive a
central venous catheter (CVC) or an implantable venous
access port system (PORT) prior to therapy to assure cor-
rect drug administration and to avoid extravasation.
Depending on the type of cancer, one or more cytostatic
drugs are intravenously administered via a CVC or a
PORT, as well as parenteral nutrition or other medica-
tions, for instance, against nausea and emesis or for stom-
ach protection. In addition, NaCl 0.9% rinsing solutions
are used for cleaning catheters of cytostatic drugs and to
ensure the patency of the catheter system. All these de-
scribed administrations are designated as “intervention” in
the following text.
CVC’s or PORT’s are usually supplemented with a
large bore extension and a three-way cock (TWC). After
each medical intervention or cleaning procedure, the ac-
cess to the catheter system must be disconnected and
then reconnected according to a high hygienic standard
by means of a luer lock cap. Figure 1 shows an example
of a TWC closed with a blue luer lock cap at the C-port,
here the “Discofix 3SC®” from B. Braun Melsungen,
Germany, which we use on our ward. The shown luer
lock cap is called “Combi-Stopper, blue®” and made by
Dispomed Witt OHG, Gelnhausen, Germany. Even ap-
propriate hygienic intervention maintenance carries
the risk of contaminating the middle port (C-port) of a
TWC, with the possible consequences of bacteremia
and sepsis e.g. in patients with Staphylococcus aureus
colonization of intravascular catheters [3], a risk that
increases with the number of interventions per day [4].Figure 1 TWC-luer lock cap (ACTUAL-condition): Blue luer lock cap
at C-port of TWC (example of TWC, here “Discofix 3SC®” from B.
Braun Melsungen, Germany. Example of luer lock cap, here
“Combi-Stopper, blue®” from Dispomed Witt OHG, Gelnhausen, Germany).For some time, different companies offered as an alter-
native to the luer lock cap for avoiding health risks due to
contamination of TWC hubs (C-ports) luer access split
septum systems (Figure 2). Luer access split septum sys-
tems do not require an additional luer lock cap (Figure 1)
because the hub is closed by a silicone split septum. An
infusion set can be directly connected to the system after
the outer silicone surface of the luer access split septum
system has been cleaned with an alcohol pad or an anti-
septic. Thus, this device represents a “closed access sys-
tem” that reduces the risk of contamination of TWC hubs
to a minimum.
To avert patient injuries, each medical facility in
Germany is obligated by law to quality assurance. An im-
portant part is hygienic risk management, and particularly
Article 1 of the German Law on the Prevention and Con-
trol of Infectious Diseases (German abb.: IfSG) explicitly
refers to the direct responsibility of hospitals [5,6].
Because a lower rate of interventions may also be
equated with better hygiene, we compared luer lock caps
with the new luer access split septum system with regard
to the following topics:
1. hygiene (patient safety)
2. process optimization (work simplification, process time)
3. efficiency (costs)
Methods
Our comparison of the two systems and their applica-
tion was thereby thematically divided into two phases:
Phase 1/Efficiency and work simplification
Phase 2/Hygiene and patient safety
Phase 1/Efficiency and work simplification
The workflow of an intervention according to the usual
practice (ACTUAL) was depicted in a process diagram
(Figure 3). During each step of the course of theFigure 2 TWC-BD-Q-Syte ® (NOMINAL-condition): Transparent
Q-Syte at C-port of TWC.
Figure 3 Work process intervention: TWC-luer lock cap (ACTUAL).
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rienced nurses who had worked at our clinic for many
years. The individual steps were logged in the process
diagram. The steps are marked with numbers in each
diagram, e.g.
1. demand: intervention/drug administration
2. walk to storage
3. pick up material
4. BD-Posiflush open and discard package
5. put material on disinfected tablet
6. tablet (disinfected)
7. take tablet and walk to patient
8. welcome and talk to patient about the implement
measures
9. put the tablet on bed table
Time per every activity was measured 5 times, and the
material components of the process were recorded per
single use. These process parameters were used for pro-
gramming the process into a simulation run (n = 1000)
to determine the process costs per intervention as well
as their differences (ACTUAL vs. NOMINAL) within
the framework of a discrete event simulation [7]. The
contamination risks of the TWC-port (C-port) were re-
corded in discrete events, whereas the causes of the risks
in the work process were marked with a color code. The
analysis of a possible NOMINAL sequence (TWC BD
Q-Syte®) was similarly edited (Figure 4).
For one-time usable luer lock caps, the recording of
the ACTUAL work sequence already showed variances
in terms of the preparation and application of the caps
with regard to time used or staff handling that contrib-
uted to increasing the hygienic risk. Possible work vari-
ances were, for example, caps being carried in lab coat
pockets, luer lock caps falling to the ground, and con-
tamination of caps during their removal from packaging,
even on the seal side (the position of the luer lock caps
in the packaging varies, disallowing blind removals).
Statistical analysis
The average process costs (material and labour) between
the luer access split septum system and the luer lock
cap were compared using the hypothesis test (2-sample
t-test, CI 0.95, p-value<0.05).
Phase 2/Hygiene and patient safety
In the 2nd phase of the project, cultures were carried out
at the TWC C-ports to evaluate possible contamination
and thus health risks for patients. The choice which of the
TWC C-ports was provided with the luer access split
septum system (Group A) or the conventional luer lock
cap (Group B) was by chance. Before intervention the luer
access split septum system connected to the C-port hasbeen cleaned with a wiping disinfection using an antiseptic
pad, the luer lock cap connected to the C-port has been
cleaned with a spraying disinfection.
All used TWC were from adult patients treated in the
Department of Radiooncology, University Hospital Re-
gensburg, Germany. All patients were asked in front to
give their written informed consent. The research was in
compliance with the Helsinki Declaration (http://www.
wma.net/en/30publications/10policies/b3/index.html.pdf).
An ethical committee approval for the study was not
necessary, because no human material and personal data
was used.
Culture material and microbiology
Directly after the change of a TWC, cultures were taken
of the interior of the C-port using a sterile cotton carrier
(TRANS system 110 c with Amies-gel agar without coal,
hain lifescience). The criterion for exclusion was previ-
ous administration of antibiotics.
For the culture, a sterile cotton carrier was laid onto
the ground of the C-port under sterile conditions. The
cotton carrier was then pressed at the lateral wall and
the base of the housing with rotating motions to reach
the entire inner surface of the system.
For maintaining sample quality, the procedure was
specified by means of a standard operating procedure.
The cotton carriers were kept in a transport medium
and immediately taken to a microbiological laboratory
(Department of Medical Microbiology and Hygiene,
University Hospital Regensburg, Regensburg, Germany).
The samples were then planted onto Columbia agar with
5% sheep blood (Oxoid) and McConkey agar, incubated
for 48 hours at 36 +/− 2°C, and checked for growth. A
sample was stated as positive with the presence of one
or more colony forming units (CFU). In case of a posi-
tive result (evaluated as positive sample), the bacteria
were specified by means of biochemical examination.
Samples without any signs of bacterial growth after 48
hours (no CFU) were defined as sterile and evaluated as
negative sample. We examined 50 samples of both sys-
tems in accordance with the described protocol. The 100
samples were taken from 25 patients. 12 patients belonged
to group A (4 samples each patient), 12 patients to group
B (4 samples each patient). Only one patient (two times
for admission) belonged to both groups (2 samples for
each study group).
The 24h routine changing period of TWC’s remained un-
altered in the program, so that the average intervention rate
was 4 interventions during one routine changing period.
Results
Phase 1/Economics and work simplification
The efficiency of the modified approach was tested and
calculated by means of 1000 discrete event simulation
Figure 4 Work process intervention: TWC-BD-Q-Syte ® (NOMINAL).
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time of 5.5 minutes could be reduced to 2.97 minutes.
The difference of the values was caused by the com-
partmentalized handling of the luer lock caps (design,
packaging, location) as well as by the partial work in-
tensification and “repeating rate”, for instance, by unin-
tentional dropping or premature contamination of luer
lock caps.The process instability of luer lock caps as one-time
usable articles and the related inefficiency of the actual
process are shown in Figure 3.
For calculating average process costs (labour time
multiplied with salary and material costs per use), we
used 1000 simulations resulting in 3.92 € for luer lock
caps and 2.55 € for the luer access split septum system.
The hypothesis test (Figure 5) (2-sample t-test, CI 0.95,
Figure 5 2-sample-t/process costs: The box (−plot) represents the mean 50% of the values, the upper and lower orthogonal line
(called whisker) the 25% of the superior and lower values. The line drawn through the box demonstrates the median values. The outliers are
displayed with asterisks. The line between the ACTUALcost and NOMINALcost links the mean values, the symbols in the charts stand for the
mean value of all samples, which serves as an estimate for m.
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which is very positive for hospitals.Amortization of material expenses
When comparing the mere non-personnel cost propor-
tion per intervention and work process, a non-personnel
cost-referred amortization of the BD Q-Syte® access sys-
tem can be achieved after 6 to 8 interventions during
the routine TWC change periodicity – despite the higher
initial costs of the BD Q-Syte® access system (Figure 6).
Figure 6 shows that non-personnel costs for a one-
time usable article increase linearly with multiple usage,
whereas these costs decrease per intervention for the
luer access split septum system as a re-usable article.
This difference is mainly caused by the material prop-
erty of one-time usable and re-usable articles.
Luer lock caps as one-time usable articles have to be
discarded and replaced for every intervention (mathem-
atical: adding) compared to the luer access split septum
system as a re-usable article that remains at the tree-way
cock (mathematical: division).Phase 2/Hygiene and patient safety
In phase 2, we examined the question of improved hy-
giene and risk minimization for a possible transmission
of infection to the patient. In 50 reviewed samples
(TWC’s), the contamination rate for the luer lock cap
was 8% (4 out of 50 samples were positive).In addition to the expected presence of typical skin
bacteria (especially S. epidermidis) in low (2 samples)
and high number (1 sample), we also detected a large
number of mixed gram-negative flora in a pure culture,
i.e. Escherichia coli, Klebsiella oxytoca, and Acinetobac-
ter lwoffii. This result was most likely caused by a con-
tamination of the TWC with bacteria of intestinal flora,
whose pathogenic potential is significantly higher than
of S. epidermidis.
In contrast, the contamination rate of the 50 samples
(TWC’s) with the luer access split septum system was 0%
(no bacterial growth was found in any of the 50 samples).
Additionally, possible hygienic risks (related to mater-
ial, surroundings, and staff handling) could be reduced
by 65.38% based on the discrete events in comparison of
the ACTUAL work process (Figure 3) with the NOM-
INAL work process (Figure 4).
Discussion
When new consumable products are introduced into
clinical routine, appropriate methods are often lacking
for showing possible advantages or disadvantages in a
scientific reviewable manner. If such new materials are
also associated with higher costs, the work process
should be first analyzed in detail. In this way, possible
benefits for staff and patients can be determined, and
macroeconomic decisions can be taken. The importance
of such “process analyses” for all processes in a hospital
is also increasingly reflected in the literature [6,8].
Figure 6 Amortization of material expenses per intervention: TWC with luer lock cap (TWC-llc) vs. TWC with BD Q-Syte® (TWC- BD Q-Syte®).
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duced in hospitals for a defined time period at which
end the “test phase” was compared with the “pre-situation”.
This process is time-consuming and often not reliable
enough, because staff members have to familiarize them-
selves with the new product only for a short period of time,
which often results in motivation problems that may nega-
tively affect final results.
A simulation compiled by a few employees only, who
become “integrated” into the process, creates a reliable
description of work processes and work analysis. This
description can be converted into a software-supported
simulation that can be run so frequently that it corre-
sponds to actual conditions.
Apart from saving time, the simulation also helps to
analyze own operational sequences with regard to pos-
sible optimizations, as such simulations are necessary for
the introduction of standard operation procedures (SOP)
in the context of quality management.
An analysis of the work process with regard to the
intervention at the middle port (C-port) of a TWC
followed by a simulation of 1000 interventions should
first show if working time for staff could be reduced
with the new consumable product. Secondly, the analysis
should determine the intervention threshold from which
possible higher initial costs of a new product in com-
parison to a conventional system are justified as well as
other possible advantages.
By measuring the contamination level of the two prod-
ucts, we could not only show cost efficiency benefitting
hospitals but also benefits for patients. Such analyses
should first and foremost focus on patient safety. In theirpaper “Scrub the Hub” on infection due to contamin-
ation of central venous catheters (CVC), Lockman et al.
[9] stressed that interventions carried out according to
high hygienic standard is the foremost prerequisite for
avoiding CVC infections. The cleaning intensity as well
as the technical condition of the connecting material be-
fore and after the intervention is crucial. The poorer the
cleaning, the less accessible or more complex the mater-
ial, the poorer is the quality of disinfection. In daily clin-
ical routine especially, work intensification may result in
neglecting the essential waiting period after C-port
disinfection.
A retrospective multi-center study by Hetem et al. [10]
showed a high rate of contamination of central venous
catheters at different connection sites with Staphylococcus
aureus; up to 12% of patients suffered from bacteremia
after CVC removal. The contamination rate indicated in
the trial of Casey et al. [11] with a contamination rate of
10% for the internal surfaces of TWC luers with standard
caps correspond with the data obtained in our observa-
tion. It might be objected that our observation was not a
prospective, randomized trial and reports only experience
at a single institution.
Above all, it is remarkable that the contamination of
the TWC’s was already detectable after a very short re-
tention time. The presence of gram-negative bacteria in-
dicates that contamination is not only caused by typical
skin flora but also by bacteria with a higher pathogenic
potential.
The impact of using needle-free connecting systems
for nosocomial infections has been examined in several
trials. Salgado et al. [12] could reduce a high level of
Pohl et al. BMC Infectious Diseases 2014, 14:41 Page 8 of 8
http://www.biomedcentral.com/1471-2334/14/41bacteremia after changing Split septum systems (similar
to the luer access split septum system used here) to sys-
tems with mechanical flaps (5.95 vs. 1.79 per 1000 cath-
eter days, RR 3.32, p<0.001). In a multi-center trial,
Jarvis et al. [13] also found a significant increase of the
rate of bacteremia when using systems with mechanical
flaps compared with Split septum systems or needles
(9.49 vs. 6.15 per 1000 CVC days, RR 1.54, p<0.001).
Additionally, the authors could also show the benefit of
Split septum systems, as in the second phase of the trial a
change of systems significantly decreased infection rates
(9.49 vs. 5.77 per 1,000 CVC days, RR 1.65, p<0.001). Ba-
sically, a central venous catheter is a risk factor [14] for
hospital-associated bacteremia; therefore, every interven-
tion of a catheter system necessitates a high level of
hygiene.
Conclusions
In the present research, the luer access split septum sys-
tem tested in this observation with a divided split
septum was superior to conventional luer lock caps. The
advantage of the luer access split septum system lies in
the simplified handling for staff, which results in a re-
duced risk of patient infection due to improved clinical
hygiene. Thus, the higher price of the luer access split
septum system we used compared to conventional luer
lock caps is being put into perspective when considering
the high intervention rates, for example, in intensive
care units, or the complex intravenous infusion sched-
ules, such as in cytostatic drug protocols.
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